Annual report pursuant to Section 13 and 15(d)

Warrants

v3.23.2
Warrants
12 Months Ended
Mar. 31, 2023
Warrants  
Warrants

11. Warrants

The following is a continuity schedule of the Company’s common share purchase warrants:

    

    

Weighted 

Number of

Average

Warrants

Exercise Price

Outstanding and exercisable, March 31, 2021

 

122,367

 

19.69

Expired

 

(42,684)

 

(9.38)

Outstanding and exercisable, March 31, 2022

 

79,683

 

25.22

Expired

(79,683)

(25.22)

Granted

400,000

0.40

Outstanding and exercisable March 31, 2023

400,000

0.40

During the year ended March 31, 2023 and 2022, 79,683 and 42,684 warrants, respectively, expired in accordance with their terms. During the year ended March 31, 2023 the Company granted 400,000 warrants at $0.40 per share with an expiration date of March 23, 2028.

The following is a summary of common share purchase warrants outstanding as of March 31, 2023.

Exercise

    

Number of

    

Price ($)

Warrants

Expiry Date

0.40

 

400,000

 

March 23, 2028

The weighted-average remaining contractual term of the outstanding warrants was 5 years.